Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

Eflornithine's effectiveness for women with facial hirsutism is unclear.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Women with different PCOS types have similar fertility treatment results.

Three siblings with a rare genetic condition had abnormal sexual development and chose different gender identities, needing surgery and therapy.

Female pattern hair loss affects crown, increases with age, and has limited treatments.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Microneedle therapy combined with serum effectively increases hair count in people with hair loss, with no side effects.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

The most common treatment for hair loss in the study was a 5% minoxidil solution, with women more likely to receive multiple medications. A significant number of patients also had hypothyroidism.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

The updated SALT II tool offers a more precise way to measure scalp hair loss.

Men prefer less invasive cosmetic procedures and need different treatment approaches than women.

Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.

Acquired Progressive Kinking of Hair is likely an early sign of male pattern baldness.

Hair transplantation, especially follicular unit micrografting, was the top treatment for male pattern baldness, with a focus on natural results and ongoing improvements in both surgical and medical management.

Finasteride at 2.5mg/day may help postmenopausal women with hair loss.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

New genotype linked to non-classical congenital adrenal hyperplasia found in Italian siblings.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The analysis found that alopecia areata, a hair loss condition, is not very common in Australia, affecting about 0.13% of people, with new cases most often seen in males aged 19 to 34 years.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

PRP injections improve hair thickness for baldness.

Treat pattern hair loss with finasteride and topical minoxidil.

Hirsutism is mainly caused by high androgen levels or sensitivity, with PCOS being the most common cause.